- Turing Medical appoints Kevin King as new CEO to lead the next phase of expansion.
- FDA 510(k) clearance obtained for the Bullsai platform, enhancing neurosurgical planning.
- PACE Therapy clinical trials planned to address Treatment Resistant Depression.
Turing Medical, a leader in precision brain mapping and targeting technologies, has announced the appointment of Kevin King as the new President and CEO. King is the former CEO of iRhythm Technologies (IRTC, Financial) and brings over 30 years of experience in healthcare and technology, having previously led companies like Affymetrix and Thomson Reuters Healthcare. He successfully guided iRhythm Technologies from an early-stage startup through a public offering, establishing it as a major player in digital health.
Under King's leadership, Turing Medical is set to launch a clinical trial for its PACE (Personalized Adaptive Cortical Electro-stimulation) Therapy, aimed at providing relief for patients suffering from Treatment Resistant Depression. This innovative therapy combines the precise targeting capabilities of Turing Medical’s Bullsai platform with minimally invasive neuromodulation therapy.
Recently, Turing Medical achieved FDA 510(k) clearance for its Bullsai platform, an automated cloud-based system for neurosurgical planning that provides personalized brain maps. Additionally, since 2022, the company has been successfully marketing its FIRMM and FIRMM-pix MRI motion monitoring software solutions to clinical and research customers.
"Turing Medical is poised to revolutionize neuroscience and bring hope to millions suffering from devastating neuropsychiatric disorders," proclaimed King. "I'm inspired to help translate Nico Dosenbach and Damien Fair’s pioneering work into transformative therapies that could fundamentally change how we treat brain disorders."
Founded with a mission to advance precision neurotechnology, Turing Medical is committed to developing solutions that redefine the standards of care for neurological and psychiatric disorders through minimally invasive techniques.
